默沙东陷专利诉讼泥潭 抗癌药Keytruda新剂型恐面临禁售令

智通财经
24 Apr

智通财经APP获悉,生物科技公司Halozyme Therapeutics Inc.(HALO.US)起诉默沙东(MRK.US),试图阻止其推出更易使用的重磅抗癌药Keytruda新剂型,指控这家制药巨头侵犯其知识产权。根据周四向美国新泽西地区法院提交的诉讼文件,默沙东在开发可皮下注射版Keytruda(替代静脉输注剂型)时,故意侵犯了Halozyme的专利。Halozyme要求法院禁止新版...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10